(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

MÉTODOS DE TRATAMENTO DE CÂNCER DO TRATO BILIAR USANDO ANTICORPO ANTI-PD-L1 EM COMBINAÇÃO COM QUIMIOTERAPIA

Em AnáliseInvention PatentPCT · EP2022079828

Application data

Number

112024018234

Type

Invention Patent

Filing

10/25/2022

Publication

01/28/2025

PCT

EP2022079828

Progress at the INPI

  1. Filing10/25/22
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 10/25/2022. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 01/28/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ASTRAZENECA AB

SE

See this company's full portfolio

Inventors

G. V. (pessoa física)

US

J. K. (pessoa física)

US

S. C. (pessoa física)

US

Technical data

Priority claims

US

63/321,215 · 03/18/2022

Abstract

MÉTODOS DE TRATAMENTO DE CÂNCER DO TRATO BILIAR USANDO ANTICORPO ANTI-PD-L1 EM COMBINAÇÃO COM QUIMIOTERAPIA. A presente invenção refere-se a métodos para o tratamento de câncer do trato biliar (CTB) usando um anticorpo anti-PD-L1 em combinação com quimioterapia.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

01/28/2025

RPI 2821

Alteração de dados cadastrais

#1.1

09/17/2024

RPI 2802

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.